Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 4, 2009, Pages 736-739

  Codd, Rachel ^a   Braich, Najwa ^a   Liu, Joe ^a   Soe, Cho Zin ^a   Pakchung, Amalie A H ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chemical biology; Hydroxamic acids; Suberoylanilide hydroxamic acid; Trichostatin A; Zn(II) dependent histone deacetylases

Indexed keywords

CISPLATIN; DOXORUBICIN; ELLIPTICINE; ETOPOSIDE; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A; VORINOSTAT; ZINC;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CHROMATIN; CUTANEOUS T CELL LYMPHOMA; DRUG STRUCTURE; ENZYME ACTIVITY; FOOD AND DRUG ADMINISTRATION; HUMAN; SHORT SURVEY; TRANSCRIPTION REGULATION; UPREGULATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CATIONS, DIVALENT; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MODELS, MOLECULAR; ZINC;

EID: 59649092334     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.05.026     Document Type: Short Survey

References (20)

1. Bolden J.E., Peart M.J., and Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5 (2006) 769-784
2. Braich N., and Codd R. Immobilized metal affinity chromatography for the capture of hydroxamate-containing siderophores and other Fe(III)-binding metabolites from bacterial culture supernatants. Analyst 133 (2008) 877-880
3. Codd R. Traversing the coordination chemistry and chemical biology of hydroxamic acids. Coord Chem Rev 252 (2008) 1387-1408
4. de Ruijter A.J.M., van Gennip A.H., Caron H.N., Kemp S., and van Kuilenburg A.B.P. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370 (2003) 737-749
5. Dundas J., Ouyang Z., Tseng J., Binkowski A., Turpaz Y., and Liang J. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34 (2006) W116-W118
6. Finnin M.S., Donigian J.R., Cohen A., Richon V.M., Rifkind R.A., Marks P.A., et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401 (1999) 188-193
7. Fischle W., Dequiedt F., Hendzel M.J., Guenther M.G., Lazar M.A., Voelter W., et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9 (2002) 45-57
8. Kim M.S., Blake M., Baek J.H., Kohlhagen G., Pommier Y., and Carrier F. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63 (2003) 7291-7303
9. Lahm A., Paolini C., Pallaoro M., Nardi M.C., Jones P., Neddermann P., et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A 104 (2007) 17335-17340
10. Mai A. The therapeutic uses of chromatin-modifying agents. Expert Opin Ther Targets 11 (2007) 835-851
11. Minetti G.C., Colussi C., Adami R., Serra C., Mozzetta C., Parente V., et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat Med 12 (2006) 1147-1150
12. Minucci S., and Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6 (2006) 38-51
13. Nielsen T.K., Hildmann C., Dickmanns A., Schwienhorst A., and Ficner R. Crystal structure of a bacterial class 2 histone deacetylase homologue. J Mol Biol 354 (2005) 107-120
14. Richon V.M., Emiliani S., Verdin E., Webb Y., Breslow R., Rifkind R.A., et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc Natl Acad Sci U S A 95 (1998) 3003-3007
15. Salisbury C.M., and Cravatt B.F. Activity-based probes for proteomic profiling of histone deacetylase complexes. Proc Natl Acad Sci U S A 104 (2007) 1171-1176
16. Schuetz A., Min J., Allali-Hassani A., Schapira M., Shuen M., Loppnau P., et al. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. J Biol Chem 283 (2008) 11355-11363
17. Somoza J.R., Skene R.J., Katz B.A., Mol C., Ho J.D., Jennings A.J., et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12 (2004) 1325-1334
18. Taunton J., Hassig C.A., and Schreiber S.L. A mammalian histone deacetylase related to a yeast transcriptional regulator Rpd3. Science 272 (1996) 408-411
19. Xu W.S., Parmigiani R.B., and Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26 (2007) 5541-5552
20. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265 (1990) 17174-17179